| 1,000 Ways to die: natural compounds modulate non-canonical cell death pathways in cancer cells B Orlikova, M Dicato, M Diederich Phytochemistry reviews 13, 277-293, 2014 | 4 | 2014 |
| Anti-inflammatory and anticancer drugs from nature B Orlikova, N Legrand, J Panning, M Dicato, M Diederich Advances in nutrition and cancer, 123-143, 2014 | 114 | 2014 |
| Anti-leukemic properties of aplysinopsin derivative ee-84 alone and combined to bh3 mimetic a-1210477 S Song, S Kim, ER El-Sawy, C Cerella, B Orlikova-Boyer, G Kirsch, ... Marine drugs 19 (6), 285, 2021 | 10 | 2021 |
| Anti-proliferative, cytotoxic and NF-ĸB inhibitory properties of spiro (lactone-cyclohexanone) compounds in human leukemia MM Bouhenna, B Orlikova, O Talhi, B Schram, DCGA Pinto, N Taibi, ... Anticancer Research 37 (9), 5225-5233, 2017 | 11 | 2017 |
| Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation B Orlikova-Boyer, A Lorant, SR Gajulapalli, C Cerella, M Schnekenburger, ... Biomarker Research 12 (1), 47, 2024 | | 2024 |
| Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer JY Lee, O Talhi, D Jang, C Cerella, A Gaigneaux, KW Kim, JW Lee, ... Cancer letters 416, 94-108, 2018 | 39 | 2018 |
| Decrypting the labyrinth of inflammatory cell signaling pathways: Editorial to the meeting “Inflammation 2010” M Kelkel, B Orlikova, M Diederich Journal of cell communication and signaling 4, 159-160, 2010 | | 2010 |
| Dietary chalcones with chemopreventive and chemotherapeutic potential B Orlikova, D Tasdemir, F Golais, M Dicato, M Diederich Genes & nutrition 6, 125-147, 2011 | 309 | 2011 |
| Embellicines A and B: Absolute configuration and NF-κB transcriptional inhibitory activity W Ebrahim, AH Aly, V Wray, A Mándi, MH Teiten, F Gaascht, B Orlikova, ... Journal of medicinal chemistry 56 (7), 2991-2999, 2013 | 46 | 2013 |
| Epipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential H Harms, B Orlikova, S Ji, D Nesaei-Mosaferan, GM König, M Diederich Marine Drugs 13 (8), 4949-4966, 2015 | 26 | 2015 |
| Eurycomanone and Eurycomanol from Eurycoma longifolia Jack as Regulators of Signaling Pathways Involved in Proliferation, Cell Death and Inflammation S Hajjouli, S Chateauvieux, MH Teiten, B Orlikova, M Schumacher, ... Molecules 19 (9), 14649-14666, 2014 | 67 | 2014 |
| Hydroquinone-derivatives induce cell death in chronic Myelogenous leukemia S Song, C Cerella, B Orlikova-Boyer, A Al-Mourabit, M Diederich Proceedings 11 (1), 28, 2019 | 1 | 2019 |
| Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ... Cancer letters 438, 197-218, 2018 | 33 | 2018 |
| Inflammation regulates long non-coding RNA-PTTG1-1: 1 in myeloid leukemia S Chateauvieux, A Gaigneaux, D Gérard, M Orsini, F Morceau, ... haematologica 105 (6), e280, 2020 | 2 | 2020 |
| Inhibitory effect of St. John׳ s Wort oil macerates on TNFα-induced NF-κB activation and their fatty acid composition IE Orhan, M Kartal, AR Gülpinar, G Yetkin, B Orlikova, M Diederich, ... Journal of ethnopharmacology 155 (2), 1086-1092, 2014 | 25 | 2014 |
| Marine polyether phycotoxin palytoxin induces apoptotic cell death via Mcl-1 and Bcl-2 downregulation J Kim, S Ji, JY Lee, J Lorquin, B Orlikova-Boyer, C Cerella, A Mazumder, ... Marine drugs 21 (4), 233, 2023 | 1 | 2023 |
| Metabolism 2014--alterations of metabolic pathways as therapeutic targets. S Ji, J Kim, B Orlikova, M Diederich Biochemical Pharmacology 92 (1), 1-2, 2014 | | 2014 |
| Methylenedioxy flavonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells B Orlikova, JC Menezes, S Ji, SP Kamat, JAS Cavaleiro, M Diederich European journal of medicinal chemistry 84, 173-180, 2014 | 30 | 2014 |
| Natural and synthetic flavonoids: structure–activity relationship and chemotherapeutic potential for the treatment of leukemia JC Menezes, B Orlikova, F Morceau, M Diederich Critical reviews in food science and nutrition 56 (sup1), S4-S28, 2016 | 95 | 2016 |
| Natural chalcones as dual inhibitors of HDACs and NF-κB B Orlikova, M Schnekenburger, M Zloh, F Golais, M Diederich, ... Oncology reports 28 (3), 797-805, 2012 | 105 | 2012 |
Marc DiederichProfessor, College of Pharmacy, Seoul National University, South Korea; LBMCC, LuxembourgVerified email at snu.ac.kr